US5112824A
(en)
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
DE4212748A1
(de)
|
1992-04-16 |
1993-10-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
GB9420999D0
(en)
|
1994-10-18 |
1994-12-07 |
Smithkline Beecham Plc |
Novel compounds
|
WO1996018617A1
(en)
|
1994-12-12 |
1996-06-20 |
Merck & Co., Inc. |
Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
|
GB9500580D0
(en)
|
1995-01-12 |
1995-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
SI0808312T1
(lt)
|
1995-02-02 |
2001-02-28 |
Smithkline Beecham Plc |
|
US5668148A
(en)
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
GB9517559D0
(en)
|
1995-08-26 |
1995-10-25 |
Smithkline Beecham Plc |
Novel compounds
|
US5886186A
(en)
|
1995-10-25 |
1999-03-23 |
Versicor, Inc. |
Synthesis of substituted N-heteroaromatic compounds and methods of use thereof
|
JP2000507590A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
US5872136A
(en)
|
1996-04-03 |
1999-02-16 |
Merck & Co., Inc. |
Arylheteroaryl inhibitors of farnesyl-protein transferase
|
FR2763944B1
(fr)
|
1997-06-03 |
2000-12-15 |
Centre Nat Rech Scient |
Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
|
JPH1149676A
(ja)
|
1997-07-31 |
1999-02-23 |
Geron Corp |
ピリジン系テロメラーゼ阻害剤
|
JPH11209366A
(ja)
|
1998-01-23 |
1999-08-03 |
Nissan Chem Ind Ltd |
クロマン誘導体及び心不全治療薬
|
JP4533534B2
(ja)
|
1998-06-19 |
2010-09-01 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
グリコーゲンシンターゼキナーゼ3のインヒビター
|
AR019190A1
(es)
|
1998-07-08 |
2001-12-26 |
Sod Conseils Rech Applic |
Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
|
CA2367340A1
(en)
|
1999-03-16 |
2000-09-21 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
HU230538B1
(hu)
|
2000-08-14 |
2016-11-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Szubsztituált pirazolok és ezeket tartalmazó gyógyszerkészítmények
|
AU2001288706B2
(en)
|
2000-09-06 |
2006-01-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
A method for treating allergies using substituted pyrazoles
|
AU2001292276A1
(en)
|
2000-09-27 |
2002-04-08 |
Toray Industries, Inc. |
Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient
|
HN2001000224A
(es)
|
2000-10-19 |
2002-06-13 |
Pfizer |
Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
|
US6710058B2
(en)
|
2000-11-06 |
2004-03-23 |
Bristol-Myers Squibb Pharma Company |
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
|
AU2002239508B9
(en)
|
2000-12-07 |
2005-09-08 |
Gilead Palo Alto, Inc. |
Substituted 1, 3, 5-triazines and pyrimidines as ABCA-1 elevating compounds against coronary artery disease or atherosclerosis
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
BR0207390A
(pt)
|
2001-02-21 |
2004-10-13 |
Nps Pharma Inc |
Compostos, composições farmacêuticas e métodos de tratatamento de doença associada a ativação e a ativação do grupo i mg1ur
|
DE60229059D1
(de)
|
2001-05-08 |
2008-11-06 |
Univ Yale |
Proteomimetische verbindungen und verfahren
|
WO2003042190A1
(en)
|
2001-11-12 |
2003-05-22 |
Pfizer Products Inc. |
N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
JP2003192673A
(ja)
|
2001-12-27 |
2003-07-09 |
Bayer Ag |
ピペラジンカルボキシアミド誘導体
|
WO2003062224A1
(en)
|
2002-01-17 |
2003-07-31 |
Eli Lilly And Company |
Aza-cyclic compounds as modulators of acetylcholine receptors
|
JP4167848B2
(ja)
|
2002-04-10 |
2008-10-22 |
広栄化学工業株式会社 |
ビアリール化合物の製造法
|
CN1181065C
(zh)
|
2002-05-08 |
2004-12-22 |
上海医药工业研究院 |
芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
|
US20040082627A1
(en)
|
2002-06-21 |
2004-04-29 |
Darrow James W. |
Certain aromatic monocycles as kinase modulators
|
US7015227B2
(en)
|
2002-06-21 |
2006-03-21 |
Cgi Pharmaceuticals, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
CA2495386C
(en)
|
2002-08-14 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
AU2003302084A1
(en)
|
2002-11-15 |
2004-06-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
EP1594512A4
(en)
|
2003-02-11 |
2007-07-11 |
Kemia Inc |
COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
|
CL2004000234A1
(es)
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
NZ544009A
(en)
|
2003-07-24 |
2009-07-31 |
Euro Celtique Sa |
Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
|
TWI287567B
(en)
|
2003-07-30 |
2007-10-01 |
Chi Mei Optoelectronics Corp |
Light-emitting element and iridium complex
|
JP2007501805A
(ja)
|
2003-08-08 |
2007-02-01 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ピリジルピペラジニルウレア
|
AU2004265191A1
(en)
|
2003-08-14 |
2005-02-24 |
Asahi Kasei Pharma Corporation |
Substituted arylalkanoic acid derivative and use thereof
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2005030704A1
(en)
|
2003-09-24 |
2005-04-07 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
EP1715867A4
(en)
|
2004-02-12 |
2009-04-15 |
Merck & Co Inc |
BIPYRIDYL AMIDES AS MODULATORS OF GLUTAMATE METABOTROPIC REPEATER-5
|
BRPI0508230A
(pt)
|
2004-03-30 |
2007-07-17 |
Chiron Corp |
derivados de tiofeno substituìdo como agentes anti-cáncer
|
PT1735278E
(pt)
|
2004-04-01 |
2010-03-09 |
Lilly Co Eli |
Agentes receptores h3 de histamina, sua preparação e utilizações terapêuticas
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
FR2869904B1
(fr)
|
2004-05-07 |
2006-07-28 |
Fournier S A Sa Lab |
Modulateurs des recepteurs lxr
|
SI1786790T1
(sl)
|
2004-07-26 |
2009-10-31 |
Lilly Co Eli |
Derivati oksazola kot agenti histamin h3 receptorja, priprava in terapevtska uporaba
|
US20090018145A1
(en)
|
2004-10-19 |
2009-01-15 |
Compass Pharmaceuticals Llc |
Compositions and their use as anti-tumor agents
|
EP1814856A1
(en)
|
2004-11-12 |
2007-08-08 |
Galapagos N.V. |
Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes
|
US8946444B2
(en)
|
2004-11-23 |
2015-02-03 |
Ptc Therapeutics, Inc. |
Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
|
DE602005013819D1
(de)
|
2004-12-22 |
2009-05-20 |
Astrazeneca Ab |
Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
PL2354126T3
(pl)
|
2005-01-14 |
2014-03-31 |
Chemocentryx Inc |
Sulfonamidy heteroarylowe i CCR2
|
EP1683796A1
(en)
|
2005-01-24 |
2006-07-26 |
Schering Aktiengesellschaft |
Pyrazolopyridines, their preparation and their medical use
|
EP1844003A4
(en)
|
2005-01-27 |
2010-09-22 |
Astrazeneca Ab |
NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
US20060235028A1
(en)
|
2005-04-14 |
2006-10-19 |
Li James J |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
EP1879548A2
(en)
|
2005-05-13 |
2008-01-23 |
Ciba Specialty Chemicals Holding Inc. |
Process for coloring keratin fibers comprising metal complexes
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
MX2007015002A
(es)
|
2005-06-02 |
2008-02-15 |
Bayer Cropscience Ag |
Derivados de heteroarilo sustituidos con fenilalquilo.
|
JP2008543754A
(ja)
|
2005-06-09 |
2008-12-04 |
メルク エンド カムパニー インコーポレーテッド |
チェックポイントキナーゼの阻害剤
|
WO2006137772A1
(en)
|
2005-06-20 |
2006-12-28 |
Astrazeneca Ab |
New physical form of n,n´- disubstituted oxabispidines
|
EP1910298B1
(en)
|
2005-06-24 |
2010-01-13 |
Brystol-Myers Squibb Company |
Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
|
WO2007005510A1
(en)
|
2005-06-30 |
2007-01-11 |
Janssen Pharmaceutica N.V. |
N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
FR2892412B1
(fr)
|
2005-10-26 |
2008-05-16 |
Galderma Res & Dev |
Composes biaromatiques modulateurs des ppars
|
TW200804307A
(en)
|
2005-10-27 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Process for preparing mesylate salts of IL-12 inhibitory compounds
|
US8026260B2
(en)
|
2005-11-03 |
2011-09-27 |
Merck Sharp & Dohme Corp. |
Histone deacetylase inhibitors with aryl-pyrazolyl-motifs
|
PT1945632E
(pt)
|
2005-11-08 |
2013-12-24 |
Vertex Pharma |
Moduladores heterocíclicos de transportadores de cassete de ligação a atp
|
WO2007055374A1
(ja)
|
2005-11-14 |
2007-05-18 |
Mitsubishi Tanabe Pharma Corporation |
骨粗鬆症治療剤
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
WO2007064797A2
(en)
|
2005-11-30 |
2007-06-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-met and uses thereof
|
AU2006328602B2
(en)
|
2005-12-23 |
2012-05-31 |
F. Hoffmann-La Roche Ag |
Aryl-isoxazolo-4-yl-oxadiazole derivatives
|
AU2007208495A1
(en)
|
2006-01-12 |
2007-08-02 |
Merck Sharp & Dohme Corp. |
Hydroxyalkylarylamide derivatives
|
WO2007087129A2
(en)
|
2006-01-12 |
2007-08-02 |
Merck & Co., Inc. |
Fluorinated arylamide derivatives
|
TW200813015A
(en)
|
2006-03-15 |
2008-03-16 |
Mitsubishi Pharma Corp |
2-(cyclic amino)-pyrimidone derivatives
|
JP2007283748A
(ja)
|
2006-03-23 |
2007-11-01 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
WO2007126765A2
(en)
|
2006-03-27 |
2007-11-08 |
The Regents Of The University Of California |
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
|
CA2648804C
(en)
|
2006-04-07 |
2014-05-27 |
Methylgene Inc. |
Benzamide derivatives as inhibitors of histone deacetylase
|
WO2007125984A1
(ja)
|
2006-04-28 |
2007-11-08 |
Nihon Nohyaku Co., Ltd. |
イソキサゾリン誘導体及び有害生物防除剤並びにその使用方法
|
EP2016068A1
(en)
|
2006-05-03 |
2009-01-21 |
AstraZeneca AB |
Pyrazole derivatives and their use as pi3k inhibitors
|
EP2016075A1
(en)
|
2006-05-03 |
2009-01-21 |
AstraZeneca AB |
Thiazole derivatives and their use as anti-tumour agents
|
US20080064871A1
(en)
|
2006-05-26 |
2008-03-13 |
Japan Tobacco Inc. |
Production Method of Nitrogen-Containing Fused Ring Compounds
|
JP2009538877A
(ja)
|
2006-05-31 |
2009-11-12 |
ガラパゴス・ナムローゼ・フェンノートシャップ |
変性疾患及び炎症性疾患の治療に有用なトリアゾロピラジン化合物
|
US20100022547A1
(en)
|
2006-06-02 |
2010-01-28 |
Brandeis University |
Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
US8778977B2
(en)
|
2006-06-30 |
2014-07-15 |
Sunesis Pharmaceuticals, Inc. |
Pyridinonyl PDK1 inhibitors
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
WO2008010985A2
(en)
|
2006-07-20 |
2008-01-24 |
Merck & Co., Inc. |
Phosphorus derivatives as histone deacetylase inhibitors
|
GB0614579D0
(en)
|
2006-07-21 |
2006-08-30 |
Black James Foundation |
Pyrimidine derivatives
|
KR20090029274A
(ko)
|
2006-07-21 |
2009-03-20 |
아이알엠 엘엘씨 |
Itpkb 억제제로서의 화합물 및 조성물
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
CA2658887C
(en)
|
2006-07-28 |
2016-08-23 |
University Of Connecticut |
Fatty acid amide hydrolase inhibitors
|
WO2008016643A2
(en)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
US20080119457A1
(en)
|
2006-08-24 |
2008-05-22 |
Serenex, Inc. |
Benzene, Pyridine, and Pyridazine Derivatives
|
WO2008024970A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Tetrahydroindolone and tetrahydroindazolone derivatives
|
CN101796056A
(zh)
|
2006-09-18 |
2010-08-04 |
沃泰克斯药物股份有限公司 |
c-MET的杂环抑制剂及其用途
|
EA015488B1
(ru)
|
2006-10-18 |
2011-08-30 |
Пфайзер Продактс Инк. |
Содержащие диариловый эфир соединения мочевины
|
DE102006050515A1
(de)
|
2006-10-26 |
2008-04-30 |
Bayer Healthcare Ag |
Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
US20100099676A1
(en)
|
2006-11-02 |
2010-04-22 |
Shionogi & Co., Ltd. |
Sulfonylurea derivative capable of selectively inhibiting mmp-13
|
JP2009023986A
(ja)
|
2006-11-08 |
2009-02-05 |
Pharma Ip |
抗癌剤としてのビアリール誘導体
|
US20080145816A1
(en)
|
2006-12-15 |
2008-06-19 |
Hershey Adrienne A |
Yankauer suction device
|
PT2125822E
(pt)
|
2006-12-21 |
2015-01-30 |
Nerviano Medical Sciences Srl |
Derivados de pirazol-quinazolina substituídos, processo para sua preparação e seu uso como inibidores da quinase
|
AR064660A1
(es)
|
2006-12-26 |
2009-04-15 |
Mitsubishi Tanabe Pharma Corp |
Derivados de pirimidinona 6-heterociclica 2-sustituida, medicamentos que los contienen y usos para prevenir y/o tratar enfermedades neurodegenerativas entre otras
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
JP2008179067A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
JP2008179068A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
ES2702362T3
(es)
|
2007-01-31 |
2019-02-28 |
Ym Biosciences Australia Pty |
Compuestos a base de tiopirimidina y usos de los mismos
|
US8324240B2
(en)
|
2007-03-20 |
2012-12-04 |
Curis, Inc. |
Fused amino pyridine as HSP90 inhibitors
|
US20080234297A1
(en)
|
2007-03-20 |
2008-09-25 |
Changgeng Qian |
HSP90 Inhibitors Containing a Zinc Binding Moiety
|
WO2008119015A2
(en)
|
2007-03-27 |
2008-10-02 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
FR2915198B1
(fr)
|
2007-04-18 |
2009-12-18 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
|
CA2684701A1
(en)
|
2007-04-20 |
2008-10-30 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2008139152A1
(en)
|
2007-05-11 |
2008-11-20 |
Sentinel Oncology Limited |
N-oxide-containing pharmaceutical compounds
|
NZ581817A
(en)
|
2007-06-03 |
2012-05-25 |
Univ Vanderbilt |
Benzamide mglur5 positive allosteric modulators and methods of making and using same
|
CL2008001632A1
(es)
|
2007-06-05 |
2009-10-16 |
Sanofi Aventis |
Compuestos derivados de acidos benzoilamino-indan-2-carboxilicos sustituidos, inhibidores del receptor cxcr5; composicion farmaceutica; y su uso en el tratamiento de efecciones fisiologicas inflamatorias, tales como artritis reumatoidea y asma.
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
CA2692153A1
(en)
|
2007-06-27 |
2009-01-08 |
Richard W. Heidebrecht, Jr. |
Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
|
UY31281A1
(es)
|
2007-08-13 |
2009-03-31 |
|
Aminas, benzamidas y sulfonamidas {[4-(5,6-dimetil-2-piridin-2-il-piridin-3-il) oxipiridin-2-il]amino} sustituidas, sus sales farmacéuticamente aceptables, composiciones contenniéndolas y aplicaciones.
|
CA2698511C
(en)
|
2007-09-04 |
2016-10-11 |
The Scripps Research Institute |
Substituted pyrimidinyl-amines as protein kinase inhibitors
|
US8354383B2
(en)
|
2007-09-17 |
2013-01-15 |
Enanta Pharmaceuticals, Inc. |
6,11-bridged biaryl macrolides
|
EP2197552B1
(en)
|
2007-09-19 |
2012-11-21 |
4Sc Ag |
Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
|
NZ584279A
(en)
|
2007-09-19 |
2011-11-25 |
4Sc Ag |
Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
|
EP2203412A4
(en)
|
2007-10-16 |
2012-01-11 |
Univ Northeastern |
MONOACYLGLYCEROLLIPASE HEMMER FOR MODULATION OF CANNABINOIDACTIVITY
|
US20090156825A1
(en)
|
2007-11-26 |
2009-06-18 |
Heidebrecht Jr Richard W |
Fluorescent compounds that bind to histone deacetylase
|
WO2009078992A1
(en)
|
2007-12-17 |
2009-06-25 |
Amgen Inc. |
Linear tricyclic compounds as p38 kinase inhibitors
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
EP2244709A4
(en)
|
2008-02-07 |
2012-02-29 |
Synta Pharmaceuticals Corp |
TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS
|
JP2009209090A
(ja)
|
2008-03-04 |
2009-09-17 |
Mitsui Chemicals Inc |
殺虫剤及び該殺虫剤に含まれる化合物、並びに該化合物の使用方法
|
CL2009000600A1
(es)
|
2008-03-20 |
2010-05-07 |
Bayer Cropscience Ag |
Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas.
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
JP5767965B2
(ja)
|
2008-06-10 |
2015-08-26 |
プレキシコン インコーポレーテッドPlexxikon Inc. |
キナーゼを調節する5h−ピロロ[2,3−b]ピラジン誘導体、およびその適応症
|
US8110576B2
(en)
|
2008-06-10 |
2012-02-07 |
Plexxikon Inc. |
Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
|
KR20110026481A
(ko)
|
2008-06-20 |
2011-03-15 |
메타볼렉스, 인코포레이티드 |
아릴 gpr119 작동약 및 이의 용도
|
NZ589962A
(en)
|
2008-06-27 |
2012-12-21 |
Novartis Ag |
Inhibitors of stearoyl-CoA desaturase and uses thereof
|
MX2011000392A
(es)
|
2008-07-11 |
2011-03-01 |
Irm Llc |
4-fenoxi-metil-piperidinas como moduladoras de la actividad de gpr119.
|
TW201028381A
(en)
|
2008-07-14 |
2010-08-01 |
Shionogi & Co |
Pyridine derivative having ttk inhibition activity
|
PE20110105A1
(es)
|
2008-07-15 |
2011-02-25 |
Novartis Ag |
Derivados de heteroarilo como inhibidores de dgat1
|
CA2735929C
(en)
|
2008-09-19 |
2013-12-17 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
CA2738448A1
(en)
|
2008-09-29 |
2010-04-01 |
Boehringer Ingelheim International Gmbh |
New chemical compounds
|
WO2010046780A2
(en)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
WO2010068863A2
(en)
|
2008-12-12 |
2010-06-17 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
ES2567047T3
(es)
|
2008-12-23 |
2016-04-19 |
Abbvie Inc. |
Derivados de pirimidina anti-virales
|
WO2010088574A1
(en)
|
2009-01-30 |
2010-08-05 |
Sirtris Pharmaceuticals, Inc. |
Azabenzimidazoles and related analogs as sirtuin modulators
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
WO2010108921A1
(en)
|
2009-03-27 |
2010-09-30 |
Nerviano Medical Sciences S.R.L. |
N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
|
WO2010112520A1
(en)
|
2009-04-01 |
2010-10-07 |
Novartis Ag |
Spiro derivatives for the modulation of stearoyl-coa desaturase
|
JP5767631B2
(ja)
|
2009-05-07 |
2015-08-19 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
バニロイド受容体リガンドとしての置換された芳香族カルボキサミドおよび尿素誘導体
|
JP2011006408A
(ja)
|
2009-05-29 |
2011-01-13 |
Sumitomo Chemical Co Ltd |
神経栄養因子の活性が関与する疾患の治療または予防剤
|
BRPI1010884A2
(pt)
|
2009-06-08 |
2016-03-15 |
Gilead Sciences Inc |
composto inibidores hdac de alcanoilamino benzamida anilina
|
WO2010151747A1
(en)
|
2009-06-26 |
2010-12-29 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimine compounds and methods of making and using same
|
WO2011008931A2
(en)
|
2009-07-15 |
2011-01-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Arylpyrimidine compounds and combination therapy comprising same for treating cystic fibrosis & related disorders
|
US8415381B2
(en)
|
2009-07-30 |
2013-04-09 |
Novartis Ag |
Heteroaryl compounds and their uses
|
AU2010327936B2
(en)
|
2009-12-11 |
2015-08-20 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
CN102791731B
(zh)
|
2009-12-16 |
2016-04-20 |
诺沃—诺迪斯克有限公司 |
Glp-1类似物和衍生物
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
JP2013522376A
(ja)
|
2010-03-24 |
2013-06-13 |
メディカル ユニバーシティー オブ サウス カロライナ |
変性疾患を治療するための組成物および方法
|
EP2730561B1
(en)
|
2010-04-06 |
2015-10-14 |
Nippon Soda Co., Ltd. |
Methods to prepare haloalkyl nitrogen-containing heterocyclic compounds
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
US8217044B2
(en)
|
2010-04-28 |
2012-07-10 |
Hoffmann-La Roche Inc. |
Spiroindolinone pyrrolidines
|
AR088020A1
(es)
|
2010-06-30 |
2014-05-07 |
Ironwood Pharmaceuticals Inc |
Compuestos heterociclicos como estimuladores de sgc
|
US20130109682A1
(en)
|
2010-07-06 |
2013-05-02 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
EP2606056A4
(en)
|
2010-08-20 |
2014-01-08 |
Harvard College |
HIGH QUALITY PALLADIUM FLUORIDE COMPLEXES AND ITS USES
|
JP2012107001A
(ja)
|
2010-10-22 |
2012-06-07 |
Shionogi & Co Ltd |
インドールアミド化合物を含有する医薬
|
WO2012061337A1
(en)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Fgfr2 modulators
|
MX341531B
(es)
|
2010-11-09 |
2016-08-22 |
Ironwood Pharmaceuticals Inc |
Derivados de triazol como estimuladores de la guanilato ciclasa soluble gcs.
|
WO2012074050A1
(ja)
|
2010-12-01 |
2012-06-07 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板、液晶表示装置、及び化合物
|
WO2012085789A1
(en)
|
2010-12-21 |
2012-06-28 |
Koninklijke Philips Electronics N.V. |
Agents for clearing biomolecules from circulation
|
CN103429571A
(zh)
|
2010-12-22 |
2013-12-04 |
普渡制药公司 |
作为钠通道阻断剂的取代吡啶
|
US20120184572A1
(en)
|
2011-01-13 |
2012-07-19 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
CN103339110A
(zh)
|
2011-01-28 |
2013-10-02 |
诺瓦提斯公司 |
作为cdk9抑制剂的取代的杂-联芳基化合物及其用途
|
US8957066B2
(en)
*
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
JP2014514257A
(ja)
|
2011-03-03 |
2014-06-19 |
ユニバーシテーテ デス ザールランデス |
選択的17ベータ−ヒドロキシステロイドデヒドロゲナーゼ2型阻害剤としてのビアリール誘導体
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
AP2013007153A0
(en)
|
2011-03-18 |
2013-09-30 |
Lupin Ltd |
Benzo [B] [1,4] oxazin derivatives as calcium sensing receptor modulators
|
WO2012147890A1
(ja)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
新規アゾール誘導体
|
WO2012149540A1
(en)
|
2011-04-28 |
2012-11-01 |
The Broad Institute Inc |
Inhibitors of histone deacetylase
|
WO2012154880A1
(en)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators for treating cystic fibrosis and other protein misfolding diseases
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
ES2920373T3
(es)
|
2011-05-16 |
2022-08-03 |
Tagworks Pharmaceuticals B V |
Activación de fármaco bioortogonal
|
JP6007417B2
(ja)
|
2011-05-31 |
2016-10-12 |
レセプトス エルエルシー |
新規glp−1受容体安定剤および調節剤
|
JP2013020223A
(ja)
|
2011-06-17 |
2013-01-31 |
Fujifilm Corp |
高分子フィルム、セルロースエステルフィルム、偏光板、及び液晶表示装置
|
CN103842357A
(zh)
|
2011-07-26 |
2014-06-04 |
格吕伦塔尔有限公司 |
作为类香草素受体配体的被取代的、含有杂芳环吡唑的羧酰胺和脲衍生物
|
US20130029961A1
(en)
|
2011-07-26 |
2013-01-31 |
Gruenenthal Gmbh |
Substituted Heterocyclic Aza Compounds
|
WO2013017480A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
CN103827092A
(zh)
|
2011-08-12 |
2014-05-28 |
巴斯夫欧洲公司 |
N-硫代邻氨基苯甲酰胺化合物及其作为农药的用途
|
WO2013033068A1
(en)
|
2011-08-30 |
2013-03-07 |
Stephen Martin Courtney |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
EP2755652B1
(en)
|
2011-09-16 |
2021-06-02 |
Novartis AG |
N-substituted heterocyclyl carboxamides
|
WO2013041602A1
(de)
|
2011-09-23 |
2013-03-28 |
Bayer Intellectual Property Gmbh |
Verwendung 4-substituierter 1-phenyl-pyrazol-3-carbonsäurederivate als wirkstoffe gegen abiotischen pflanzenstress
|
ES2572908T3
(es)
|
2011-10-14 |
2016-06-03 |
Bristol-Myers Squibb Company |
Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor XIa
|
WO2013059648A1
(en)
|
2011-10-21 |
2013-04-25 |
Neurotherapeutics Pharma, Inc. |
2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
|
AU2012321111A1
(en)
|
2011-10-31 |
2013-05-16 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9321763B2
(en)
|
2012-04-04 |
2016-04-26 |
Rigel Pharmaceuticals, Inc. |
Protein kinase C inhibitors and uses thereof
|
CN104245714B
(zh)
|
2012-04-12 |
2017-09-26 |
港大科桥有限公司 |
供oled应用的铂(ii)络合物
|
WO2013163404A1
(en)
|
2012-04-27 |
2013-10-31 |
The Uab Research Foundation |
TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
|
CN104334552B
(zh)
|
2012-05-31 |
2016-08-31 |
住友化学株式会社 |
稠合杂环化合物
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
BR112014031068A2
(pt)
|
2012-06-12 |
2017-06-27 |
Abbvie Inc |
derivados piridinona e piridazinona
|
CN104583206A
(zh)
|
2012-06-15 |
2015-04-29 |
加利福尼亚大学董事会 |
用于脑癌的新颖治疗剂
|
CN103508961B
(zh)
|
2012-06-26 |
2015-07-22 |
中美冠科生物技术(太仓)有限公司 |
抗肿瘤药物
|
US9682970B2
(en)
|
2012-06-29 |
2017-06-20 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
EP2875029B8
(en)
|
2012-07-18 |
2021-12-15 |
University of Notre Dame du Lac |
5,5-heteroaromatic anti-infective compounds
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
WO2014025808A1
(en)
|
2012-08-06 |
2014-02-13 |
The General Hospital Corporation |
Curcumin analogs
|
EP2888256A4
(en)
|
2012-08-24 |
2016-02-17 |
Univ Texas |
HETEROCYCLIC HIF ACTIVITY MODULATORS FOR THE TREATMENT OF DISEASES
|
US9309235B2
(en)
|
2012-09-18 |
2016-04-12 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
KR20150072412A
(ko)
|
2012-10-05 |
2015-06-29 |
리겔 파마슈티칼스, 인크. |
Gdf-8 억제제
|
JP2016502503A
(ja)
|
2012-10-11 |
2016-01-28 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
Tspo媒介性疾患および/または障害の治療および/または予防
|
JP2014101353A
(ja)
|
2012-10-26 |
2014-06-05 |
Shionogi & Co Ltd |
オキサジン誘導体を含有するアルツハイマー症治療用または予防用医薬組成物
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
KR20150093685A
(ko)
|
2012-11-09 |
2015-08-18 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코포레이션 |
Hbv 어셈블리 이펙터의 대체 용도
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
WO2014081303A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Chemically cleavable group
|
WO2014081301A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
JP6357167B2
(ja)
|
2012-12-04 |
2018-07-11 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
プロテインキナーゼc阻害剤およびそれらの用途
|
CN103864754B
(zh)
|
2012-12-10 |
2016-12-21 |
中国科学院上海药物研究所 |
五元唑类杂环化合物及其制备方法、药物组合物和用途
|
WO2014164704A2
(en)
|
2013-03-11 |
2014-10-09 |
The Broad Institute, Inc. |
Compounds and compositions for the treatment of cancer
|
US9045455B2
(en)
|
2013-03-14 |
2015-06-02 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
WO2014144169A1
(en)
|
2013-03-15 |
2014-09-18 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
MX2015008999A
(es)
|
2013-03-15 |
2015-09-16 |
Celgene Avilomics Res Inc |
Inhibidores mk2 y usos de los mismos.
|
JP6235048B2
(ja)
|
2013-03-20 |
2017-11-22 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
尿素誘導体及びその脂肪酸結合タンパク質(fabp)阻害剤としての使用
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
CN104163792B
(zh)
|
2013-05-20 |
2017-04-12 |
湖南化工研究院 |
N‑吡啶酰胺类化合物及其制备方法与应用
|
CN104163791B
(zh)
|
2013-05-20 |
2017-05-03 |
湖南化工研究院 |
N‑吡啶(杂)芳酰胺类化合物及其制备方法与应用
|
EP3004083A4
(en)
|
2013-05-24 |
2016-11-16 |
California Inst Biomedical Res |
COMPOUNDS FOR THE TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS
|
CN105682665A
(zh)
|
2013-05-30 |
2016-06-15 |
华盛顿大学 |
用于治疗细菌性感染的化合物和方法
|
CN110003279A
(zh)
|
2013-06-10 |
2019-07-12 |
代表亚利桑那大学的亚利桑那校董会 |
具有改进的发射光谱的磷光四齿金属络合物
|
GB2515785A
(en)
|
2013-07-03 |
2015-01-07 |
Redx Pharma Ltd |
Compounds
|
GB2516303A
(en)
|
2013-07-18 |
2015-01-21 |
Redx Pharma Ltd |
Compounds
|
US9359330B2
(en)
|
2013-08-26 |
2016-06-07 |
Purdue Pharma L.P. |
Substituted piperidines as sodium channel blockers
|
WO2015031725A1
(en)
|
2013-08-30 |
2015-03-05 |
President And Fellows Of Harvard College |
Transition metal-catalyzed imidation of arenes
|
PE20160880A1
(es)
|
2013-09-06 |
2016-09-22 |
Inception 2 Inc |
Compuestos de triazolona y usos de los mismos
|
US9663508B2
(en)
|
2013-10-01 |
2017-05-30 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
EP3055287B1
(en)
|
2013-10-08 |
2019-11-06 |
Lu, Qing-Bin |
Non-platinum-based anti-cancer compounds for use in targeted chemotherapy
|
SI3060550T1
(sl)
|
2013-10-21 |
2019-09-30 |
Merck Patent Gmbh |
Heteroarilne spojine kot inhibitorji BTK in uporabe le-teh
|
CA2931097A1
(en)
|
2013-11-19 |
2015-05-28 |
Vanderbilt University |
Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mglur5
|
CN103601718A
(zh)
|
2013-12-05 |
2014-02-26 |
江西天人生态股份有限公司 |
一类基于鱼泥丁受体的邻甲酰氨基苯甲酰胺衍生物及其制备方法和用途
|
WO2015110999A1
(en)
|
2014-01-24 |
2015-07-30 |
Piramal Enterprises Limited |
Ezh2 inhibitors and uses thereof
|
CN103804312B
(zh)
|
2014-02-17 |
2016-04-20 |
四川百利药业有限责任公司 |
一类氮杂环化合物及其制备方法和用途
|
WO2015142903A2
(en)
|
2014-03-17 |
2015-09-24 |
Genentech, Inc. |
Method of controlling lactate production with piperdine-dione derivatives
|
US9533982B2
(en)
|
2014-03-20 |
2017-01-03 |
Vanderbilt University |
Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
|
GB201405002D0
(en)
|
2014-03-20 |
2014-05-07 |
Isis Innovation |
Fluorination method
|
ES2898633T3
(es)
|
2014-04-09 |
2022-03-08 |
Lumiphore Inc |
Macrociclos
|
EP3140298A1
(en)
|
2014-05-07 |
2017-03-15 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
WO2015187542A1
(en)
*
|
2014-06-02 |
2015-12-10 |
Chdi Foundation Inc. |
Histone deacetylase inhibitors and compositions and methods of use thereof
|
US20170349540A1
(en)
|
2014-07-28 |
2017-12-07 |
The General Hospital Corporation |
Histone deacetylase inhibitors
|
WO2016020307A1
(en)
|
2014-08-04 |
2016-02-11 |
Fundación Para La Investigación Médica Aplicada |
Novel compounds for use in cognition improvement
|
ES2959097T3
(es)
|
2014-08-18 |
2024-02-20 |
Hudson Biopharma Inc |
Espiropirrolidinas como inhibidores de MDM2
|
GB201416513D0
(en)
|
2014-09-18 |
2014-11-05 |
Astex Therapeutics Ltd And Cancer Res Technology Ltd |
Pharmaceutical compounds
|
US9550778B2
(en)
|
2014-10-03 |
2017-01-24 |
Vanderbilt University |
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5
|
CA2963681A1
(en)
|
2014-10-08 |
2016-04-14 |
Acetylon Pharmaceuticals, Inc. |
Induction of gata2 by hdac1 and hdac2 inhibitors
|
US10308648B2
(en)
|
2014-10-16 |
2019-06-04 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
MY190408A
(en)
|
2014-10-16 |
2022-04-21 |
Sage Therapeutics Inc |
Compositions and methods for treating cns disorders
|
WO2016100711A1
(en)
|
2014-12-18 |
2016-06-23 |
The Broad Institute, Inc. |
Modulators of hepatic lipoprotein metabolism
|
CN105777632A
(zh)
|
2015-01-09 |
2016-07-20 |
成都贝斯凯瑞生物科技有限公司 |
芳环并氮杂环衍生物及其应用
|
EP3259264B1
(en)
|
2015-02-20 |
2022-07-27 |
Rigel Pharmaceuticals, Inc. |
Gdf-8 inhibitors
|
CA2983314A1
(en)
|
2015-04-30 |
2016-11-03 |
Memorial Sloan-Kettering Cancer Center |
Mitragynine analogs and uses thereof
|
WO2016173557A1
(zh)
|
2015-04-30 |
2016-11-03 |
中国科学院上海药物研究所 |
一类具有激酶抑制活性的化合物、制备方法和用途
|
WO2016183266A1
(en)
|
2015-05-13 |
2016-11-17 |
Enanta Pharmaceuticals, Inc. |
Ehpatitis b antiviral agents
|
WO2017007756A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc |
Hetero-halo inhibitors of histone deacetylase
|
WO2017007755A1
(en)
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
WO2017027984A1
(en)
|
2015-08-20 |
2017-02-23 |
Simon Fraser University |
Compounds and methods for treatment of cancer by inhibiting atg4b and blocking autophagy
|
WO2017044889A1
(en)
|
2015-09-10 |
2017-03-16 |
The Regents Of The University Of California |
Lrh-1 modulators
|
EP3362436B1
(en)
|
2015-09-14 |
2021-06-30 |
Universiteit Antwerpen |
Process for the catalytic directed cleavage of amide-containing compounds
|
CA3003930A1
(en)
|
2015-11-04 |
2017-05-11 |
Simon Fraser University |
Antibiotic compounds, pharmaceutical formulations thereof and methods and uses therefor
|
TWI773657B
(zh)
|
2015-12-18 |
2022-08-11 |
美商亞德利克斯公司 |
作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
|
MX2018010176A
(es)
|
2016-02-23 |
2019-01-21 |
Taiho Pharmaceutical Co Ltd |
Compuesto novedoso de pirimidina condensada o sal del mismo.
|
CA3015817A1
(en)
|
2016-03-09 |
2017-09-14 |
President And Fellows Of Harvard College |
Direct palladium-catalyzed aromatic fluorination
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|
AU2017363268A1
(en)
|
2016-11-23 |
2019-05-30 |
Regenacy Pharmaceuticals, Llc |
Piperazine derivatives as selective HDAC1,2 inhibitors
|
ES2909086T3
(es)
|
2017-01-11 |
2022-05-05 |
Alkermes Inc |
Inhibidores bicíclicos de histona desacetilasa
|
CN106946890A
(zh)
|
2017-04-26 |
2017-07-14 |
中国药科大学 |
吡啶类irak4抑制剂、其制备方法及应用
|
HRP20220648T1
(hr)
|
2017-08-07 |
2022-09-02 |
Alkermes, Inc. |
Biciklički inhibitori histonske deacetilaze
|
CN112805275A
(zh)
|
2018-07-13 |
2021-05-14 |
奥克梅斯公司 |
组蛋白脱乙酰酶双环抑制剂
|
MA53129A
(fr)
|
2018-07-13 |
2021-05-19 |
Alkermes Inc |
Inhibiteurs de l'histone désacétylase
|